Consistently, the mRNA and protein levels of α-SMA in the SSc model were significantly higher than those in control mice (P < 0.001) and were reduced to normal levels after BMSC-EV treatment (P < 0.001) (Fig. 5f, g, h). This evidence concerns the gene ACTA1 and systemic sclerosis.